Predictors of Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection
Authors:
Preprint
Abstract
Objective Patients with cervical artery dissection (CAD) are at increased ischemic stroke risk. We aimed to identify characteristics that are associated with increased risk of ischemic stroke following initial presentation of CAD and to evaluate the differential impact of anticoagulant versus antiplatelet therapy in these high-risk individuals. Methods This was a secondary analysis of the Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection (STOP-CAD) study, a multicenter retrospective observational study. The primary outcome was subsequent ischemic stroke by day 180 after diagnosis. Patient characteristics were compared between those with vs. without subsequent ischemic stroke. Significant predictors were identified using stepwise Cox regression. Associations between subsequent ischemic stroke risk and antithrombotic therapy type in high-risk patients were explored using adjusted Cox regression. Results 4,023 patients (mean age 47.4 years; 44.5% were women) were included. By day 180, 5.3% experienced a subsequent ischemic stroke. In adjusted Cox regression, factors associated with increased subsequent ischemic stroke risk were prior ischemic stroke (aHR 7.31, 95% CI 1.61-33.13, p=0.010), presentation within seven days from symptoms, (aHR 3.04, 95% CI 1.04-8.91, p=0.043), infarct on imaging (aHR 9.85, 95% CI 3.65-26.58, pInterpretation This study identified several predictors of subsequent ischemic stroke among patients with CAD but only patients with occlusive dissection demonstrated a benefit from anticoagulation. These findings require validation by meta-analyses of prior studies.Keywords
This publication has 18 references indexed in Scilit:
- Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart AssociationStroke, 2024
- Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT‐CAD Randomized TrialAnnals of Neurology, 2024
- Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trialThe Lancet Neurology, 2021
- Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trialThe Lancet Neurology, 2015
- New ischaemic brain lesions in cervical artery dissection stratified to antiplatelets or anticoagulantsEuropean Journal of Neurology, 2015
- Incidence and Outcome of Cerebrovascular Events Related to Cervical Artery Dissection: The Dijon Stroke RegistryInternational Journal of Stroke, 2013
- Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic StrokeStroke, 2009
- Treatment of cervical artery dissection: a systematic review and meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Cervical artery dissection?clinical features, risk factors, therapy and outcome in 126 patientsJournal of Neurology, 2003
- Outcome in Patients with Symptomatic Occlusion of the Internal Carotid Artery or Intracranial Arterial Lesions: A Meta-Analysis of the Role of Baseline Characteristics and Type of Antithrombotic TreatmentCerebrovascular Diseases, 2001